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Management of lipids, particularly signaling lipids that control neuroinflammation, is crucial
for the regeneration capability of a damaged nervous system. Knowledge of pro- and
anti-inflammatory signals after nervous system injury is extensive, most of them being
proteins acting through well-known receptors and intracellular cascades. However, the role
of lipid binding extracellular proteins able to modify the fate of lipids released after injury is
not well understood. Apolipoprotein D (ApoD) is an extracellular lipid binding protein of the
Lipocalin family induced upon nervous system injury. Our previous study shows that axon
regeneration is delayed without ApoD, and suggests its participation in early events during
Wallerian degeneration. Here we demonstrate that ApoD is expressed by myelinating and
non-myelinating Schwann cells and is induced early upon nerve injury. We show that
ApoD, known to bind arachidonic acid (AA), also interacts with lysophosphatidylcholine
(LPC) in vitro. We use an in vivo model of nerve crush injury, a nerve explant injury model,
and cultured macrophages exposed to purified myelin, to uncover that: (i) ApoD regulates
denervated Schwann cell-macrophage signaling, dampening MCP1- and Tnf-dependent
macrophage recruitment and activation upon injury; (ii) ApoD controls the over-expression
of the phagocytosis activator Galectin-3 by infiltrated macrophages; (iii) ApoD controls
the basal and injury-triggered levels of LPC and AA; (iv) ApoD modifies the dynamics
of myelin-macrophage interaction, favoring the initiation of phagocytosis and promoting
myelin degradation. Regulation of macrophage behavior by Schwann-derived ApoD is
therefore a key mechanism conditioning nerve injury resolution. These results place
ApoD as a lipid binding protein controlling the signals exchanged between glia, neurons
and blood-borne cells during nerve recovery after injury, and open the possibility for a
therapeutic use of ApoD as a regeneration-promoting agent.
Keywords: Lipocalin, sciatic nerve, myelin phagocytosis, myelin degradation, macrophage, arachidonic acid,
lysophosphatidylcholine
INTRODUCTION
A detailed knowledge of the cellular and molecular mechanisms
underlying the degeneration and restoration processes following
an injury is fundamental to understand a set of basic physiolog-
ical processes in the nervous system, as well as the regenerative
potential of neurons suffering a degenerative condition. A wealth
of information has been gathered in the last two decades concern-
ing factors impacting on neuronal survival and axon regeneration
following diverse forms of injury in the central (CNS) and periph-
eral nervous system (PNS) (reviewed by Vargas and Barres, 2007;
Huebner and Strittmatter, 2009; Gaudet et al., 2011).
The degeneration and regeneration capabilities of the PNS
have been deeply studied after Waller described the process in
the XIX century (Koeppen, 2004). A number of molecular players
involved in all steps of the Wallerian degeneration-regeneration
process (WDR) of the PNS (axon degeneration and growth inhi-
bition, myelin breakdown and clearance, and ultimately axon
regeneration and remyelination) have been studied thoroughly.
However, many details of this complex process are still unknown,
and studying the role of newly uncovered implicated proteins is
essential to fully understand it.
The Lipocalin Apolipoprotein D (ApoD) was initially related
to the WDR of the PNS due to its injury-dependent over-
expression in the rat peripheral nerve (Boyles et al., 1990; Spreyer
et al., 1990). Our long-standing interest in this protein and its
insect homologs led us to study the role of ApoD using geneti-
cally modified mouse models and a sciatic nerve crush paradigm
(Ganfornina et al., 2010). By studying WDR at 14 and 48 days
post-injury in genetically-modified mice with altered expression
levels of ApoD, we uncovered affected cellular and molecular
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processes that contradicted the initial working hypothesis propos-
ing that ApoD was implicated in remyelination, a late process
that occurs after axon regeneration is permitted. Our results
demonstrated earlier roles for ApoD facilitating myelin clearance,
extracellular matrix remodeling and, later on, axon regenera-
tion, but the molecular processes controlled by ApoD still remain
unknown.
In this work we study an early stage of WDR, 7 days after a
crush injury, in wild-type (WT) and ApoD-deficient (ApoD-KO)
mice. At this time an injured nerve is at the mid-point of active
axonal regrowth, and Schwann cells are switching into a distinct
regeneration-promoting phenotype (Arthur-Farraj et al., 2012),
thus representing a key point to analyze the early roles predicted
for ApoD. In order to isolate the variables modified by ApoD we
undertake three different levels of analysis: in vivo, using the sci-
atic nerve crush injury model; ex vivo, using cultured explants
of sciatic nerves; and in vitro phagocytosis assays with primary
macrophages fed with purified myelin. We also study the cellular
source and localization of ApoD in response to injury.
MATERIALS AND METHODS
ANIMALS, SURGERY, AND INJURY PROCEDURES
Mice used in this study were age- and sex-matched littermates of
two genotypes: Wild type (WT) and loss-of-function mutants for
ApoD (ApoD-KO). ApoD-KO mice were generated by homolo-
gous recombination. The mutation is evidenced by PCR, in all
experimental mice used, genotyping with two different primer
pairs, as described previously (Ganfornina et al., 2008). In order
to avoid potential maternal effects of ApoD, and to generate WT
and ApoD-KO mice of homogenous genetic background, the
experimental cohorts used in this study are the F1 generation
of homozygous crosses of ApoD−/− and ApoD+/+ littermates
born from heterozygous crosses of an ApoD-KO line backcrossed
for over 20 generations into the C57BL/6J background. Mice
were maintained in positive pressure-ventilated racks at 25 ±
1◦C with 12 h light/dark cycle, fed ad libitum with a standard
rodent pellet diet (Global Diet 2014; Harlan Inc., Indianapolis,
IN, USA), and allowed free access to filtered and UV-irradiated
water.
Animals subjected to surgery and injury procedures (n =
21/genotype, 8 months old) were anesthetized via intraperitoneal
injection with ketamine (100mg/kg) and xylazine (10mg/kg).
Sciatic nerve crush was performed by compressing the nerve
three times, 20 s each, with #5 forceps. Subsequently, muscles
and skin were sutured and the animals were allowed to recover
in a warmed cage. Sciatic nerves from both the injured and the
control contralateral legs were removed 7 days post-crush injury
(dPCI). A 2–3mm fragment of the nerve distal to the lesion was
stored at−80◦C for RNA and protein expression analysis, and the
remaining nerve was fixed and used in different experiments as
explained below. Alternatively the nerve injury site fragment was
stored at −80◦C and used for lipid extraction.
Experimental procedures were approved by the University of
Valladolid Animal Care and Use Committee and followed the
regulations of the Care and the Use of Mammals in Research
(European Commission Directive 86/609/CEE, Spanish Royal
Decree 1201/2005).
IMMUNOHISTOCHEMISTRY
Nerve samples (n = 15 pairs/genotype) were fixed with 4%
paraformaldehyde overnight at 4◦C and embedded in paraf-
fin following standard procedures. Longitudinal sections (4μm)
were performed with a rotary microtome (Microm), mounted in
seven series on polysine slides (Menzel-Gläser), and dried.
Sections were dewaxed in xylene and rehydrated through
an ethanol series into phosphate buffered saline (PBS). Before
HRP immunohistochemisty, endogenous peroxidase was inac-
tivated with H2O2 (0.9% in distilled H2O) for 5min in the
dark, followed by washes in PBS. Sections were then blocked
and permeabilized with Triton X-100 (0.25% in PBS) and 1%
normal goat serum (except for primary goat antibodies). The
following antibodies were used: Rat monoclonal anti-Galectin
3 (American Type Culture Collection, ATCC); Rabbit serum
anti-Mbp (Abcam); Goat polyclonal anti-Integrin αM (CD11b)
(Santa Cruz Biotechnology); Goat polyclonal anti-ApoD (Santa
Cruz Biotechnology); Mouse monoclonal anti-GFAP (Santa Cruz
Biotechnology); HRP-conjugated Goat anti-Rat IgG (Abcam);
HRP-conjugated Goat anti-Rabbit IgG and Goat anti-Mouse IgG
(Dako); HRP-conjugated Donkey anti-Goat IgG (Santa Cruz
Biotechnology). HRP development was performed with DAB
(0.03%) and H2O2 (0.002% in 50mM Tris, pH 8.0) in par-
allel for all sections probed with the same antibody. Sections
were mounted with coverslips and Eukitt after dehydration and
clearing with xylene.
For fluorescence immunohistochemistry, the following anti-
bodies were used: Rat monoclonal anti-Galectin 3 (ATCC); Goat
polyclonal anti-ApoD (Santa Cruz Biotechnology); Rabbit anti-
S100 (Zymed); Mouse anti-GFAP (Santa Cruz Biotechnology);
FITC-conjugated Goat anti-Rat, and Cy3.5-conjugated Goat anti-
Rabbit (Abcam). After several washes in PBS, sections were
mounted with Vectashield-DAPI (Vector Labs).
For Luxol Fast Blue (LFB) staining, sections were incubated in
LFB solution at 37◦C overnight, washed in 95% ethanol, differen-
tiated in 0.005% lithium carbonate followed by 70% ethanol, and
mounted after dehydration and clearing in Eukitt.
Sections were visualized and photographed with an Eclipse
90i (Nikon) fluorescence microscope equipped with a DS-Ri1
(Nikon) digital camera. Confocal images were obtained in a DMI
6000B microscope with TCS SP5 X confocal system and a WLL
laser (Leica) controlled by LAS AF software (Leica).
QUANTITATIVE RT-PCR
Distal portions of nerves (n = 6/genotype) or cells used for
mRNA expression studies were stored at −80◦C and RNA was
extracted with RNeasy Lipid Tissue Mini Kit (Qiagen) using
QIAzol Lysis Reagent (Qiagen). RNA concentration was mea-
sured with a Nanodrop spectrophotometer and quality assessed
by agarose electrophoresis. Following DNAse treatment, 500 ng
of total RNA was reverse-transcribed with PrimeScript (Takara
Bio Inc., Otsu, Japan) according to the manufacturer instruc-
tions by using Oligo-dT primers and random hexamers. The
resulting cDNA was used as template for quantitative real-time
RT-PCR using SybrGreen (SYBR® Premix Ex Taq™ kit, Takara).
The primers used for RT-qPCR are shown in Table 1. Rpl18 was
used as the reference gene.
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Table 1 | Primers used for quantitative real-time RT-PCR.
Primer name Sequence
Mouse Rpl18-Forward 5′-TTCCGTCTTTCCGGACCT
Mouse Rpl18-Reverse 5′-TCGGCTCATGAACAACCTCT
Mouse ApoD-Forward 5′-GAAGCCAAACAGAGCAACG
Mouse ApoD-Reverse 5′-TGTTTCTGGAGGGAGATAAGGA
Mouse Ccl2-Forward 5′-TCCCTGTCATGCTTCTGGGCCT
Mouse Ccl2-Reverse 5′-GCTTCTTTGGGACACCTGCTGCT
Mouse Tnf-Forward 5′-TCTTCTCATTCCTGCTTGTGGCAG
Mouse Tnf-Reverse 5′-TGGTTTGCTACGACGTGGGCT
Mouse Il1b-Forward 5′-TGTAATGAAAGACGGCACACCCAC
Mouse Il1b-Reverse 5′-GGCTTGTGCTCTGCTTGTGAGG
Mouse Il10-Forward 5′-CAGAGCCACATGCTCCTAGAGC
Mouse Il10-Reverse 5′-GGCCATGCTTCTCTGCCTGGG
Mouse Il6-Forward 5′-CACATGTTCTCTGGGAAATCGTGGA
Mouse Il6-Reverse 5′-CTCCAGGTAGCTATGGTACTCCAGAA
Mouse Emr1-Forward 5′-AAGCAGTGCAGGGCAGGGAT
Mouse Emr1-Reverse 5′-GCAAGATGGTGCCCAGAGTGGA
Mouse Cpla2-Forward 5′-GTGAGGGGCTTTATTCCACA
Mouse Cpla2-Reverse 5′-GGTGAGAGTACAAGGTTGACA
Mouse Mmp9-Forward 5′-TACACGGAGCACGGCAACGG
Mouse Mmp9-Reverse 5′-CGCACAGCTCTCCTGCCGAG
Transcription levels of mRNA were estimated with the CT
method (Livak and Schmittgen, 2001). Transcripts were nor-
malized to Rpl18 for each condition. Statistically significant dif-
ferences of gene transcriptional changes were evaluated with a
Mann-Whitney U-test (Yuan et al., 2006) using CT of each
replica (calculated by subtracting the average CT of the reference
gene for each sample). The statistical level of significance was set
at P < 0.05.
IMMUNOBLOT ANALYSIS
Peritoneal macrophages or distal fragments of each nerve (n =
8/genotype) were pooled by experimental condition and geno-
type, and proteins were extracted from the organic phase of
QIAzol Lysis Reagent-treated samples after RNA extraction fol-
lowing the manufacturer’s protocol. Total protein concentration
was evaluated by bicinchoninic acid assay (MicroBCA, Pierce,
Rockford, IL, USA).
Immunoblot analyses were performed with 10–20μg of total
protein/lane transferred to PVDF membranes using standard
procedures and exposed to the following primary antibodies:
Rat monoclonal anti-Galectin 3 (ATCC); Goat polyclonal anti-
ApoD and Goat polyclonal anti-Integrin αM (CD11b) (Santa
Cruz Biotechnology, Inc.); Rabbit polyclonal anti-Mbp (Abcam);
Rabbit polyclonal anti cPLA2 alpha, and rabbit polyclonal anti-
phospho cPLA2 alpha (Cell Signaling); Mouse anti-GFAP (Santa
Cruz Biotechnology, INC). HRP-conjugated Goat anti-Rat, Goat
anti-Mouse or Donkey anti-Goat IgG (Santa Cruz Biotechnology,
Inc.) were used as secondary antibodies. HRP-conjugated anti-β
actin antibody (Sigma, St Louis, MO, USA) was used to normal-
ize protein loads. Membranes were developed with ECL reagents
(Millipore, Billerica, MA, USA), and the signal visualized with
a digital camera (VersaDoc, BioRad). The integrated optical
density of the immunoreactive protein bands was measured in
images taken within the linear range of the camera, avoiding
signal saturation.
MYELIN ISOLATION AND LABELING
Myelin was isolated from whole brain of 3 month-old mice by
sucrose density-gradient centrifugation, according to the Norton
and Poduslo method (1973). We used six independent myelin
preparations per genotype (n = 3 brains/preparation). Myelin
protein content was determined with MicroBCA Protein Assay
(Pierce) and monitored by SDS-PAGE and Coomassie blue stain-
ing. Myelin (1mg/ml) was fluorescently labeled by incubation
with 12.5mg/ml of the lipophilic dye 1,1′′-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanide perchlorate (DiI; Sigma) for 30min
at 37◦C. Excess of DiI was removed by washing with sterile
PBS followed by centrifugation (20min at 24000 g). Myelin
fluorescence was determined in a Shimadzu RF-5301PC spec-
trofluorometer. Excitation wavelength was 545 nm. Fluorescence
emission was recorded from 490 to 600 nm. Labeled myelin was
stored in small aliquots at −20◦C in the dark.
Myelin particle area and total counts were measured using
ImageJ software (Rasband, W.S., ImageJ, U. S. National Institutes
of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/,
1997–2014) and thresholded images of DiI-labeled myelin prepa-
rations freshly spread on microscope slides.
PRIMARY CULTURE OF PERITONEAL MACROPHAGES
Peritoneal macrophages were harvested in 5ml cold PBS, either
as naïve cells or 4 days after an intraperitoneal injection of
2.5ml of 3% thioglycollate (TG) (Difco, USA) in 4–8 month-
old mice (n = 6/genotype). The cells were subsequently washed
in PBS and cultured in Dulbecco’s Modified Eagle’s medium
(DMEM) with 10% heat-inactivated fetal bovine serum (FBS),
1% L-Glutamine and 1% P/S/A solution (Penicillin 10U/μL,
Streptomycin 10μg/μL, Amphotericin B 25μg/mL), henceforth
called “complete medium.”
MYELIN PHAGOCYTOSIS ASSAY
Macrophages were plated in 24-well tissue culture plates (7.5 ×
105 cells/well) in the presence of complete medium for 5 h. Non-
adherent cells were removed by washing twice with PBS, and 1ml
of complete medium was added. Over 95% of the cultured cells
were macrophages as determined by immunofluorescence with
macrophage markers. The cells were incubated with 5μg of DiI-
labeled myelin (10μg/ml) for 90min at 37◦C in 5% CO2. After
the incubation period, non-phagocytosed and unbound myelin
was removed by washing twice with PBS. Cells were detached
by incubation at 37◦C in 5% CO2for 10min with Trypsin/EDTA
(Lonza) and using a cell scraper. After resuspension in PBS,
the amount of myelin phagocytosed was determined by measur-
ing cellular fluorescence intensity recorded in the FL2 channel
(560–590 nm) of a Gallios Flow Cytometer (Beckman Coulter).
The histograms of control macrophages without myelin at each
time point were used to define the fluorescence threshold value
to consider events as DiI positive macrophages. The percentage
of positive cells was used as a measure for binding and uptake
of the DiI-labeled myelin. The percentage of myelin-positive
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macrophages was plotted against time of myelin exposure, and
the rate of change of this variable was calculated as the slope of
the curve obtained between 20 and 60min. Phagocytosis anal-
yses were performed in 3–4 independent experiments, with 3
macrophage-myelin samples/experiment).
Fluorescence microscopy was used to visualize myelin uptake
by macrophages. For this purpose, 2.5 × 105 cells were cultured
on 12mm coverslips and 5μg of DiI-labeled myelin (10μg/ml)
was added per well in complete medium. Cells were incu-
bated at 37◦C in 5% CO2. Following incubation and extensive
washout of non-phagocytosed myelin particles with PBS, cells
were fixed in 4% formaldehyde in PBS, washed in PBS and
mounted with Vectashield-DAPI (Vector Labs). Labeled cells were
visualized with an Eclipse 90i (Nikon) fluorescence microscope
equipped with a DS-Ri1 (Nikon) digital camera. The area and
total counts of myelin particles ingested by cultured macrophages
in 60min were measured from thresholded images with ImageJ
software.
For the exogenous addition of ApoD, human ApoD purified
from breast cystic fluid (Ruiz et al., 2013) was added at differ-
ent concentrations (10–100 nM) to the myelin preparation 5min
before its addition to the macrophage culture.
SCIATIC NERVE EXPLANTS MODEL FOR EX VIVO ANALYSIS OF
WALLERIAN DEGENERATION
To study axonal degeneration ex vivo, sciatic nerves were dis-
sected from adult WT and ApoD-KOmice (n = 3/genotype), and
their epineurium was removed. Nerve segments of ∼5mm were
incubated on a Nucleopore Track-Etch Membrane (Whatman)
in 4-well dishes containing 500μL of DMEM with 10% heat-
inactivated FBS, 1% L-Glutamine and 1% P/S solution (Penicillin
10 U/μL, Streptomycin 10μg/μL,). Explants were cultured at
37◦C and 5% CO2 for 7 days, with a change of medium every
2 days. At day 7, the medium was removed and the nerves were
washed with PBS before freezing them at −80◦C.
MASS SPECTROMETRY ANALYSIS OF LIPIDS FROM INJURED NERVES
AND FROMMYELIN
Lipids from intact and injured nerves (n = 6/genotype) were
extracted using a modified Bligh and Dyer (1959) method, using
0.1 N HCl instead of water. The extracted lipids were resus-
pended in 150μL of methanol:water (9:1, v/v) and kept at−20◦C
until analysis. Protein concentration in the extracted samples
was estimated by MicroBCAanalysis (Pierce). Ultraperformance
liquid chromatography interfaced to a time-of-flight mass spec-
trometer (UPLC-QToF-MS) was performed using an Acquity
UPLC System and SYNAPT HDMS G2 (Waters, Milford,
USA). A two solvent gradient elution was used for compound
separation on an Acquity BEH C18 column (2.1 × 50mm,
1.7μm particle size, temperature 30◦C), as follows: (i) ini-
tial, 80% A; (ii) 0–1min, 80% A; (iii) 1.0–5.5min, 100%
B; (iv) 5.5–7.5min, 100% B; and (v) 7.5–10.0min: 80% A.
Solvent A consisted of methanol/water/formic acid (50:50:0.5,
v/v/v) with 5mM ammonium formate, and solvent B contained
methanol/acetonitrile/formic acid (59:40:0.5, v/v/v) with 5mM
ammonium formate. The flow rate used was 0.5mL/min, and
the injection volume was 7.5μL. Compounds were detected as
positive ions using a MSE method with low (full scan) and
high (fragmentation at 20–30V) energy functions. MS parame-
ters were: capillary, 0.9 V; sample cone, 18V; source temperature,
90◦C; desolvation temperature, 450◦C; cone gas, 20 L/h; desolva-
tion gas, 900 L/h. Analysis in negative mode was also conducted
in order to obtain data on the acyl chains esterifying the glycerol
backbone. Compounds were identified by m/z search within ±
0.01Da in the LIPIDMAPS database (www.lipidmaps.org) and
coincidence of the elemental formula composition. Specific frag-
ments obtained with the high energy function were used to
confirm phospholipid class identification (m/z 184.07 for PCs in
positive-ion mode; m/z 196.01 for PEs and m/z 223.03 or m/z
241.02 for PIs in negative-ion mode). The areas of the chro-
matographic peaks obtained in the extracted ion chromatogram
(EIC) from the full scan (low-energy function) were determined
by integration using the MassLynx software tool.
Arachidonic acid (AA) and lysophosphatidylcholines (LPC)
were analyzed in lipid extracts from pools of 6 control and 6
injured (injury site, 7d-PCI) fragments (≈1mm3) per genotype.
AA was measured in negative-ion mode using the UPLC-MS
method described in Municio et al. (2013), whereas LPCs were
measured in positive-ionmode as indicated above. Total LPC nor-
malized to protein content are represented as percentage of WT
control nerves. The AA concentration in extracts was calculated
after a linear regression of peak area to concentration was deter-
mined using an AA external standard (Sigma-Aldrich, A9673).
AA concentration normalized to protein content is plotted.
Whole brain myelin was extracted from 6 to 7 pools (2
brains each) per genotype. Independent lipid extracts were
prepared from each pool as explained above, and deuterated
internal standards (Avanti Polar Lipids) for each of six major
phospholipid classes were added (25 ng each): [2H31]16:0/18:1-
PA, [2H31]16:0/18:1-PC, [2H31]16:0/18:1-PE, [2H31]16:0/18:1-
PG, [2H31]16:0/18:1-PI and [2H31]16:0/18:1-PS. Samples were
analyzed by LC/MS/MS using an API3200 triple quadrupole mass
spectrometer (AB SCIEX) connected to an HPLC dual pump
system (Shimadzu). Samples were dried under a stream of dry
nitrogen gas and dissolved in 100μL of a mixture of 75% HPLC
solvent C (hexanes/isopropanol 30:40, v/v) and 25% solvent D
(5mM ammonium acetate in hexanes/isopropanol/water 30:40:7,
v/v/v). Normal-phase chromatography was performed using a sil-
ica column (Ascentis, 150 × 2.1mm, 5μm particle size, Supelco)
at a flow rate of 200μL/min. Solvent D wasmaintained at 25% for
5min, increased gradually to 60% in 10min and then to 95% in
5min, and was held for 20min before re-equilibration for 15min.
Analysis was performed in the negative-ion mode using multiple-
reaction monitoring (MRM) of different molecular species con-
taining combinations of the more common fatty acyl chains
(Steinhauer et al., 2009). The precursor ions monitored were the
molecular ions [M-H]−, except for PC in which case the acetate
adducts [M+CH3COO]− were monitored. The product ions ana-
lyzed after collision-induced decomposition were the carboxylate
anions corresponding to the acyl chains. Results are reported as
the ratio between the integrated area of each analyte and the
integrated area of the corresponding internal standard. Since
no standard dilution curves were used, these results cannot be
used to quantify absolute amounts of the analytes, but they are
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useful to identify potential changes across the samples of different
genotypes.
LIGAND BINDING ASSAYS BY TRYPTOPHAN FLUORESCENCE
TITRATION
Ligand binding to ApoD was performed as previously described
(Sanchez et al., 2008; Ruiz et al., 2013). Fluorescence mea-
surements were conducted with a Shimadzu RF-5301PC spec-
trofluorometer with a quartz cuvette (Hellma 105.251-QS, 3mm
path length). Temperature was held at 22 ± 0.1◦C. The excita-
tion wavelength was 295 nm (selective for tryptophan residues).
Emission was recorded at the 340 nm peak with slit width set
at 5 nm. The fluorescence value was used to calculate the appar-
ent equilibrium dissociation constant (KD.) Data were analyzed
using the RFPC software package (Shimadzu). Human ApoD
from cyst fluid was diluted to a concentration of 0.5μM in
10mM phosphate buffer, 150mM NaCl, 1mM EDTA, pH 7.0, so
that the starting intrinsic fluorescence of the protein lies within
the dynamic range of measurement. A 100mM stock of LPC
(Sigma-Aldrich, L1381) was prepared in ethanol. Protein solu-
tions (100μl) were titrated with either four or eight additions of
ligand, adding each time 1 or 0.5μl aliquots of a 1:1000 dilution
of ligand in phosphate buffer. This dilution of ligand stock into
the aqueous solution was made immediately before addition to
the protein. After addition of each ligand aliquot, the mixture
was equilibrated for 2min in the dark before fluorescence was
recorded.
The fluorescence spectrum in the presence of ligand was sub-
tracted from a carrier baseline obtained by titration of the pro-
tein with the same amounts of carrier without ligand. Ethanol
final concentration was ≤0.004%. The corrected fluorescence
at 340 nm vs. the total concentration was fitted as previously
described (Sanchez et al., 2008). KD was calculated under the
assumption of a single binding site, consistent with known
Lipocalin structural properties. A tryptophan residue conserved
along the entire Lipocalin family is located at the binding pocket
surface, and is predicted to be the residue responsible for most of
the intrinsic fluorescence changes observed.
STATISTICAL ANALYSES
Statistical analyses were performed using Sigmaplot (v11.0) and
Statgraphics Plus (v5.0). A P-value of 0.05 was considered a
threshold for statistical significance.
RESULTS
Our previous work studying WDR in the sciatic nerve of mice
lacking or over-expressing ApoD (Ganfornina et al., 2010) uncov-
ered an important function for ApoD in the clearance of myelin
preceding axon regeneration. Myelin clearance is performed both
by resident Schwann cells (SCs), which transform their pheno-
type into a phagocytic repair cell, and by invading macrophages
from the bloodstream. Thus, we set up to study the effects of
changing ApoD expression levels on the WDR process 7 days
after crush injury (7d-PCI). This in vivo sciatic nerve study is
combined with in vitro phagocytosis assays in isolated primary
macrophages and an ex vivo nerve injury model, to better dissect
the molecular elements involved using experimental systems with
different degrees of cellular complexity.
ApoD EXPRESSION IN GLIAL CELLS IN THE INTACT AND INJURED
NERVE AT 7d-PCI
Before assaying the role of ApoD in the early myelin clearance
and macrophage recruitment stage of nerve injury, we first con-
firmed the induction of ApoD expression in the distal region
of crushed nerves at 7d-PCI by immunoblot (Figure 1A). ApoD
protein over-expression had been described in the rat at 21 days
after denervation (Boyles et al., 1990), but no data was available
from mice.
Knowledge of the cellular localization of ApoD is also nec-
essary in order to show its source. In the intact nerve, ApoD
immunolocalizes in cells of elongated nuclei with labeling located
along the sheaths of myelinated axons (arrows in Figure 1B).
In contrast, ApoD is absent in perineurial cells (white arrow
in Figure 1B). Cell types expressing ApoD were confirmed by
co-localization with the myelinating SC marker S100 and non-
myelinating SC marker GFAP. ApoD is observed in a subset of
myelinating (Figure 1C) and non-myelinating SCs (Figure 1D),
suggesting a dynamic spatiotemporal regulation of its expression.
Confocal microscopy and 3D-reconstructions of Z-stacks show
ApoD located in secretion vesicles (arrowhead in Figure 1E) and
the outer sheath of SCs (arrows in Figures 1E,F).
In injured nerves, and consistent with our immunoblot results
(Figure 1A), the number of ApoD-positive cells increases at 7d-
PCI, showing extensive co-localization with S100 (arrows in
Figures 1G–I). We can identify ApoD-expressing cells as S100-
positive SCs that are known to be undergoing a phenotypic
switch toward a distinct repair-focused cell at this stage after
injury (Arthur-Farraj et al., 2012). These cells are involved in
the process of myelin phagocytosis and are providing signals
to recruit hematogenous macrophages for en masse phagocyto-
sis. Interestingly, ApoD is also observed in S100-positive myelin
debris in the region distal to the injury (arrowheads in Figure 1I).
This finding is consistent with the detection of ApoD in myelin
preparations (Figure 6D, and Suresh et al., 1998; Jahn et al.,
2009).
The observed expression supports the hypothesis that glia-
derived, myelin-associated ApoD plays a role in injured nerves at
times when SCs are switching phenotypes and myelin phagocyto-
sis and macrophage recruitment are taking place.
ALTERATIONS IN WALLERIAN DEGENERATION IN THE ABSENCE OF
ApoD AT 7d-PCI
Cytokine-chemokine network response
We first monitored the transcriptional response to injury of sev-
eral cytokines, chemokines and other molecules related to WDR
in WT and ApoD-KO nerves. At 7d-PCI, the mRNA expres-
sion of the cytokine Tnf is similar to the basal level in WT
nerves, as expected after its early induction peak (Kleinschnitz
et al., 2004; Iwatsuki et al., 2013). However, Tnf mRNA is
found significantly increased in the 7d-PCI ApoD-KO nerves
(Figure 2A), suggesting a sustained expression. Since Tnf expres-
sion is down-regulated in the ApoD-KO intact nerve, injury-
dependent up-regulation of Tnf is enhanced in the absence of
ApoD. An over-response to the injury situation also occurs in
ApoD-KO mice for the chemokine and macrophage chemoat-
tractant protein MCP1, which is also induced at 7d-PCI in the
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FIGURE 1 | ApoD is over-expressed by Schwann cells at 7 days after
sciatic nerve crush injury. (A) Immunoblot analysis of ApoD in the region
distal to the nerve lesion of WT and ApoD-KO mice. High levels of ApoD
protein are observed 7d-PCI. (B) HRP-immunohistochemistry of ApoD in
sagittal sections of intact sciatic nerves. Scattered ApoD-positive cells are
seen in the endoneurium (arrows), while no labeling is seen in the
perineurium (white arrow). (C–F) Fluorescence-immunohistochemical
detection of ApoD in sagittal sections of intact sciatic nerves. Co-localization
of ApoD and S100 (arrows in C) confirms Schwann cells (SCs) as a source of
ApoD in sciatic nerves. A subset of non-myelinating SCs also expresses
ApoD as evidenced by co-localization with the GFAP marker (arrows in D)
compared to GFAP-only signal (open arrow in D). Confocal image (E) and a
3-D reconstruction of a Z-stack of confocal images (F) of fluorescence
immunohistochemistry show ApoD labeling in secretion vesicles (arrowhead
in E) and the SCs outer sheath (arrows in E,F). (G–I) Co-localization of ApoD
and the SC marker S100 in sagittal sections of a crushed WT sciatic nerve
7d-PCI at different positions with respect to the injury site. Arrows point to
ApoD labeling in intact and denervated SCs. Arrowheads in (I) (region distal
to the crush) show ApoD adjacent to S100-positive myelin debris. Calibration
bars: 50μm.
distal part of the injured nerve (Figure 2B), and its induction is
enhanced in the absence of ApoD. However, at this time after
injury we did not observe significant ApoD-dependent differ-
ences for the response of the pro-inflammatory cytokines Il6
and Il1β (Figures 2C,D), the anti-inflammatory cytokine Il10
(Figure 2E), or the matrix metalloproteinase Mmp9 (Figure 2F).
Thus ApoD-KO injured nerves show alterations in a particu-
lar subset of the cytokine-chemokine network organizing myelin
clearance. This results in an altered inflammatory state that might
result from, and influence, the activity of transdifferentiated
Schwann cells or the recruitment and activation of blood-borne
monocytes.
Cellular response
To identify which cellular responses are affected by the absence
of ApoD, we first estimated the amounts of non-myelinating
Schwann cells by measuring the expression of GFAP (Jessen
et al., 1990) in 7d-PCI nerves. Figure 3A shows similar increases
of GFAP signal after injury in WT and ApoD-KO samples,
arguing against different numbers of Schwann cells in the
ApoD-KO nerves. We then measured the expression of the
macrophage gene Emr1/F4-80 by RT-qPCR (Figure 3B), and the
expression and tissue distribution of the activated macrophage
marker CR3-Cd11b by immunohistochemistry (Figure 3C)
and immunoblot (Figure 3D) in injured nerves. The three
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FIGURE 2 | ApoD alters the expression levels of genes involved
in macrophage recruitment in vivo. Quantitative RT-PCR analyses
of (A) Tnf, (B) Ccl2/MCP1, (C) Il6, (D) Il1β, (E) Il10, and (F)
Mmp9 expression. The mRNA was extracted from the region distal
to the lesion of WT and ApoD-KO mice at 7d-PCI. The absence of
ApoD results in exacerbated Ccl2/MCP1 and Tnf signaling in the
injured nerve. The transcriptional responses of Il1β, Il6, Il10, and
Mmp9 are independent of ApoD. Statistical differences were assayed
by Mann-Whitney U-test. Asterisks show statistically significant
differences (P < 0.05).
experimental approaches indicate that macrophage numbers are
already increasing at 7d-PCI, and more so in ApoD-KO than in
WT nerves. Our previous explorations of late times after injury
(14 and 48d-PCI) show that this increase persists and enlarges
over time in the absence of ApoD, and that myelin debris accumu-
lates by 14d-PCI (Ganfornina et al., 2010). However, by 7d-PCI,
no differences in the extent of myelin clearance was observed,
as monitored by immunoblot and immunohistochemistry of
Mbp (Figures S1A,B) and by LFB histochemistry (Figure S1C).
Thus, the elevated presence of macrophages expressing CR3-
Cd11b in ApoD-KO injured nerves contrasts with the normal
myelin amounts at this stage of WDR, and suggests a differen-
tial effect of ApoD on macrophage recruitment and initiation of
phagocytosis.
We then checked the expression of Galectin-3, a factor involved
in signaling macrophages to start myelin phagocytosis, inWT and
ApoD-KO nerves (Figure 4). While nerve injury results in over-
expression of Galectin-3 protein in the wild type at 7d-PCI, a far
greater increase is found in the distal region of crushed nerves
in the absence of ApoD (Figure 4A). A number of cells express-
ing Galectin-3 in distal regions of injured WT nerves express
ApoD as well (arrowheads in Figure 4B). They are probably den-
ervated SCs undergoing their phenotypic switch toward repair-
promoting phagocytic and macrophage-recruiting cells. We have
demonstrated that peritoneal macrophages do not express ApoD
(Figure 6F). Likewise, macrophages recruited to injured WT
nerves do not show ApoD expression (arrows in Figure 4C).
However, some tissue macrophages show partial co-localization
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FIGURE 3 | The expression of macrophage markers is exacerbated in
injured nerves in the absence of ApoD. GFAP protein expression
normalized to β-actin (A) and Emr1/F4-80 mRNA expression (B) in
intact nerves and in the distal region of injured nerves of WT and
ApoD-KO mice at 7d-PCI. (C) Representative examples of CR3/Cd11b
immunohistochemistry in sagittal sections of the injury region of
crushed sciatic nerves. Arrows point to CR3-positive macrophages.
Calibration bars: 50μm. (D) Immunoblot analysis of the CR3/Cd11b
protein in the region distal to the lesion of WT and ApoD-KO mice at
7d-PCI. Statistical differences were assayed by Student’s t-Test (A,D)
and Mann-Whitney U-test (B). Asterisks show statistically significant
differences (P < 0.05).
with ApoD-positive structures (arrows in Figure 4C), which
might represent myelin particles that are being phagocytosed
(open arrows in Figure 4C). Thus, the Galectin-3-positive cells
that do not express ApoD after injury are probably macrophages
(arrows in Figure 4B).
The increased Galectin-3 expression and its dependence on
ApoD are also clear in immunohistochemistry experiments of
WT and ApoD-KO nerves (Figure 4D). Galectin-3-positive cells
represent both S100-positive SCs (arrowheads in Figure 4D) and
S100-negative macrophages that are being recruited at this time
point after injury (arrows in Figure 4D).
Resident vs. infiltrated phagocytic cells
These results led us to ask whether infiltrating macrophages are
the source of the ApoD-dependent over-expression of Galectin-3.
Alternatively, this expressionmight be due to denervated SCs cells
or resident macrophages. To solve this question we performed
nerve explant cultures and assayed protein and mRNA expres-
sion after 7 days in culture. In this ex vivo experimental model all
endogenous factors in the nerve are present, with the exception of
infiltrating macrophages. This procedure resulted in the expected
over-expression of ApoD protein in WT nerves (Figure 4E),
but we found no significant ApoD-dependent changes in the
macrophage marker Emr1/F480 (Figure 4F) or in Galectin-3
expression (Figure 4G) (representing in this case the activity
of resident cells). These results demonstrate that, in vivo, bone
marrow-derived infiltrated macrophages are the major cell type
over-expressing the phagocytosis activator Galectin-3 in ApoD-
KO injured nerves. Moreover, they further support that ApoD
over-expression in the WT injured nerves originates in nerve
resident cells.
Myelin breakdown and lipid mediators of inflammation
Since MCP1 and Tnf are known to stimulate the expression
of phospholipases that hydrolyze myelin membrane phospho-
lipids, we could expect alterations of lipase-dependent myeli-
nolysis in the absence of ApoD. We evaluated the expression of
the Ca2+-dependent cytosolic phospholipase A2 alpha (cPLA2
group IVA, hereafter referred to as cPLA2), since it is known to
be expressed by Schwann cells (Lopez-Vales et al., 2008). RT-
qPCR and immunoblot analysis of the protein and its more active
phosphorylated form are shown (Figures 5A–C). Although no
clear differences are seen in mRNA levels with injury or geno-
type, cPLA2 increased protein levels (Figures 5B,C) do reflect
the reported increased expression in response to nerve injury
(Lopez-Vales et al., 2008), suggesting that the earlier peak of
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FIGURE 4 | ApoD-dependent changes in the levels of Galectin-3
expression in nerves 7d-PCI and cultured nerve explants. (A) Immunoblot
analysis of Galectin-3 in the region distal to the lesion of WT and ApoD-KO
mice sciatic nerves. The induction of Galectin-3 protein expression by injury
is exacerbated in the ApoD-KO nerves at 7d-PCI. Basal expression of
Galectin-3 in ApoD-KO nerves is also increased compared to WT nerves. (B)
Representative micrographs of Galectin-3 and ApoD immunofluorescence
experiments in crushed WT nerves 7d-PCI. Arrows point to Galectin-3
labeling in macrophages, and arrowheads indicate co-localization of ApoD and
Galectin-3 in SCs and myelin profiles. (C) CR3/Cd11b and ApoD labeling in
sagittal sections of the injury region of WT nerves 7d-PCI. CR3/Cd11b-positive
macrophages do not express ApoD (arrows), which is present in other cells
and in myelin profiles (arrowheads). However, some macrophages show
partial co-localization with ApoD-positive myelin profiles (open arrows). (D)
Galectin-3 and S100 labeling in sagittal sections of the injury region of WT
and ApoD-KO nerves 7d-PCI. Galectin-3 labeling is more abundant in
ApoD-KO nerves, and often co-localizes with S100-positive SCs in the injured
nerves. (E–G) Analysis of nerve explants cultured for seven days. The graphs
represent the average ± SD of 3 independent culture experiments. (E)
Immunoblot analysis of ApoD shows high levels of expression in the WT
cultured nerves. (F) Emr1/F4-80 mRNA expression does not differ between
ApoD-KO and WT nerve explants, indicating similar presence of endogenous
macrophages. (G) Immunoblot analysis of Galectin-3 shows no significant
increment of expression in ApoD-KO compared to WT nerve explants.
Protein band intensities were normalized to β-actin. Calibration bars: 25μm.
Statistical differences were assayed by Student’s t-Test.
induction of cPLA2 has already taken place. Detectable higher lev-
els of phosphorylated cPLA2 expression are seen in the control
intact ApoD-KO nerve (Figures 5B,C), but no differences in
the amounts of the phosphorylated form or in its ratio to the
non-phosphorylated form are observed between genotypes upon
injury (Figure 5C). Therefore, major effects of ApoD on tran-
scription, translation, or post-translational modification of this
particular PLA2 upon injury can be discarded.
AA is one of the major products resulting from PLA2 myelin
cleavage activity, probably due to the preference of PLA2for
membrane phospholipids with AA, and it contributes to the
inflammatory response to injury. ApoD is known to bind AA
with high affinity (Morais Cabral et al., 1995; Vogt and Skerra,
2001), and nervous system disorders with altered AA levels con-
cur with ApoD over-expression (reviewed by Dassati et al., 2014).
Additionally, PLA2 cleavage activity also results in the production
of lysophospholipids. Among them, LPC are especially relevant in
the injured nerve as myelinolytic agents that contribute to build-
ing the cytokine inflammatory network and serve as a signal for
macrophage recruitment and activation (Hall and Gregson, 1971;
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FIGURE 5 | Analysis of cPLA2 expression, LPC binding to ApoD,
and quantification of LPC and free AA in the nerve upon
injury. (A) Quantitative RT-PCR of cPLA2 group IVA shows no
differences in ApoD-KO nerves 7d-PCI. (B,C) Immunoblot analysis of
phospho-cPLA2 and total cPLA2 in intact nerves and in the region
distal to the lesion. Neither the induction of cPLA2 protein
expression upon injury nor its phospho-cPLA2/total cPLA2 ratio is
ApoD-dependent. Protein band intensities were normalized to β-actin.
(D) Relative fluorescence intensity of hApoD exposed to increasing
concentrations of lysophosphatidylcholine (LPC). Dots represent the
mean of 3 independent titrations. (E,F) Mass spectrometry analyses
of LPC (E) and free arachidonic acid (AA) (F) in intact nerves and
in the injury region of WT and ApoD 7d-PCI nerves. Statistical
differences were assayed by Mann-Whitney U-test (A), and
Student’s t-Test (C–E). Asterisks show statistically significant
differences (P < 0.05).
Gregson and Hall, 1973). Binding of LPC to another Lipocalin,
α-1-acid glycoprotein, has been reported (Ojala et al., 2006),
but it has not been tested for ApoD. We therefore performed
in vitro ligand-binding assays by tryptophan fluorescence titra-
tion of purified human ApoD (Figure 5D). LPC was able to
quench intrinsic protein fluorescence in a dose-dependent man-
ner, indicating a successful interaction with a KD of 1.13μM,
similar to other ligand-ApoD interactions (Ruiz et al., 2013).
Thus, it is particularly relevant to assay the effect of an ApoD
deficiency on AA and LPC levels in the injured nerve.
Using mass spectrometry, we measured the levels of LPC and
AA in lipid extracts from the nerve injury site and contralat-
eral control nerves. Three major LPC species were detected in
the sciatic nerves: 16:0/OH-PC, 18:1/OH-PC, and 20:4/OH-PC.
In the WT nerves, one LPC species (16:0/OH-PC) was slightly
increased by injury above basal control levels, whereas levels of
18:1/OH-PC and 20:4/OH-PC are reduced upon injury. After the
expected increase of LPC upon injury, probably due to the ele-
vated cPLA2 expression and activity, the decrease in free LPCs
detected by 7d-PCI could be related to the ongoing processes
of both degradation and recycling into new membrane phos-
pholipids. The most prominent effect of the lack of ApoD is
the elevation of LPC levels in intact nerves. Also, LPC decrease
upon injury without ApoD, further decreasing total levels of
LPC (Figure 5E). AA measurements revealed an increase in WT
crushed nerves (Figure 5F), possibly related to the induction of
cPLA2 expression by injury. Interestingly, ApoD-KO intact nerves
show higher levels of free AA thanWT control nerves. In contrast,
no increase of AA is observed upon injury. Thus, ApoD controls
the basal and injury-triggered levels of LPC and AA.
In summary, our analysis of WDR in WT and ApoD-
KO sciatic nerves at 7d-PCI demonstrates that an extracellu-
lar lipid binding protein, the Lipocalin ApoD, influences the
cytokine/chemokine inflammatory network, controls the proper
activation/recruitment of phagocytic cells that remove myelin
debris, and modifies the availability of lipid mediators that are
key factors controlling the pace of the response to injury.
MYELIN CLEARANCE ASSAYS IN CULTURED PERITONEAL
MACROPHAGES
Without ApoD, an increased recruitment of activated
macrophages is present at 7d-PCI, and a robust expression
of the “eat-me” signal Galectin-3 is taking place (Figures 3, 4).
Also, the availability of some lipid mediators is modified, with
a faster depletion of both LPC and AA. We know that myelin
removal is slowed down later on in the absence of ApoD, and
Frontiers in Cellular Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 374 | 10
García-Mateo et al. ApoD-dependent repair upon PNS injury
this factor ultimately influences the pace of nerve regeneration
(Ganfornina et al., 2010). Our next aim was therefore to analyze
the process of myelin-macrophage interaction with the working
hypothesis that these phenotypes could be explained if ApoD
were a key contributor to the regulation of myelin phagocytosis
and degradation.
Myelin phagocytosis initiation
We studied myelin phagocytosis and clearance in cultured peri-
toneal macrophages to reduce the number of biological vari-
ables involved. We used myelin purified from mouse brains
(Figures 6A–D) in these experiments because of the scale
of source tissue needed. Purified myelin was labeled with
DiI (Figure 6B) and particle size distribution was analyzed
(Figure 6C) as detailed in the Materials and Methods section.
Myelin preparations from WT and ApoD-KO brains show sim-
ilar distributions of particle size and fluorescence level (nor-
malized to protein amount) (Figures 6B,C). TG-elicited mouse
peritoneal macrophages were cultured, and their cell purity was
characterized by immunocytochemistry with the macrophage
markers Emr1-F4/80 and CD11b (Figure 6E). Emr1-F4/80 gene
expression was also confirmed in primarymacrophage cultures by
RT-qPCR (Figure 6F, left panel). Macrophages lack measurable
levels of ApoD mRNA (Figure 6F, middle panel) compared with
the normal expression of ApoD in brain (Figure 6F, right panel).
We first assessed the process of phagocytosis of macrophages fed
with DiI-labeled myelin by examining DiI-positive cells in flu-
orescence microscopy (Figure S2A). We also studied the time
course of myelin phagocytosis by detecting myelin basic pro-
tein (Mbp) with immunoblot after feeding TG-elicited mouse
FIGURE 6 | Characterization and quality controls of myelin extracts and
peritoneal macrophage cultures. (A) SDS-PAGE separation of myelin
isolated from brains of WT mice stained with Coomassie blue. (B) DiI labeling
of myelin assayed by fluorimetry measurements (excitation λ = 545 nm,
emission λ = 568 nm). No differences in DiI incorporation are observed in
myelin from each mouse genotype. A representative pair of myelin
preparations is shown. (C) Size distribution of myelin particles in two
independent myelin preparations (ten 10× fields/experiment). (D)
Immunoblot analysis of ApoD in myelin preparations isolated from brains of
WT and ApoD-KO mice. The arrow points to the ApoD band. (E)
Characterization of peritoneal macrophage cultures. The cultured cells
express F4-80 and CR3/Cd11b markers, as evidenced by
immunofluorescence. Calibration bars: 50μm. (F) ApoD mRNA was not
detected by RT-qPCR in peritoneal macrophages, while the macrophage gene
Emr1/F4-80 is amplified. Brain mRNA was used to amplify ApoD as a positive
control in the same RT-qPCR.
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peritoneal macrophages with myelin and quantifying Mbp in
the cell lysates (Figure S2B). The Mbp signal peaks after 1 h
exposure, consistent with Slobodov et al. (2001). We therefore
chose a range of 20–60min of incubation of macrophages with
myelin to quantitatively assay the extent of phagocytosis by flow
cytometry.
Figure 7A shows a representative flow cytometry experi-
ment of macrophage samples after exposure to DiI-labeled
myelin. Frequency histograms of macrophage fluorescence with-
out myelin (control) and with DiI-labeled myelin are plotted. The
percentage of DiI positive macrophages is significantly smaller
upon exposure to ApoD-KO myelin at all times tested. Figure 7B
shows the overall results of WT and ApoD-KO macrophages
exposed to either WT or ApoD-KO myelin. We fitted our exper-
imental data to a single exponential function with parameters
derived from the myelin phagocytosis data analysis previously
reported by Slobodov et al. (2001). Our results show that expo-
sure to ApoD-KO myelin clearly results in a delay in the accumu-
lation of DiI-positive macrophages regardless of their genotype
(Figure 7B), suggesting an impaired myelin-macrophage recog-
nition or phagocytosis initiation.
The delay is however followed by a 1.8-fold higher accumula-
tion rate of DiI-positive macrophages for ApoD-KOmacrophages
exposed to ApoD-KO myelin (Figure 7C). When purified human
ApoD is exogenously added to ApoD-KO myelin prior to expo-
sure to ApoD-KO macrophages, and phagocytosis is allowed to
proceed up to 60min, the percentage of DiI-positive macrophages
is reduced in a dose-dependent manner (Figure 7D).
Myelin degradation
In addition to a myelin-macrophage recognition problem, the
differences in the rate of accumulation of myelin-positive
macrophages might be due to an altered myelin degradation rate
once myelin has been internalized in each macrophage. To test
this hypothesis we exposed WT and ApoD-KO macrophages to
myelin of their own genotype for 1 h. We then washed away
the unbound myelin and monitored myelin degradation by
immunoblot of two different myelin proteins, Mbp, and Mag
(Figure 8A). Myelin proteins were quantified, normalized with β-
actin, and referred to the protein amount at t = 0 (Figure 8B).
The clearance curves of both myelin proteins show that the
absence of ApoD results in a clear delay in myelin degradation.
The marked decrease in myelin degradation rate explains why
myelin-positive ApoD-KO macrophages accumulate faster over
time, even though phagocytosis initiation is delayed. The initial
delay is also confirmed with this different methodology since at
FIGURE 7 | ApoD alters the phagocytosis of myelin by cultured
peritoneal macrophages. (A) Myelin phagocytosis by TG-elicited
macrophages measured with flow cytometry after different times of
exposure to myelin of WT or ApoD-KO mouse brains. Histograms
of a representative experiment in WT macrophages are shown. The
histogram of control macrophages without myelin defines the
fluorescence threshold to classify an event as a DiI-positive
macrophage. (B) Flow cytometry evaluation of myelin phagocytosis
by TG-elicited macrophages (WT macrophages, upper panel; KO
macrophages, lower panel). Dots in graphs represent average ± SD
of 3–4 independent experiments (with 3 macrophage samples per
experiment) performed with two myelin preparations/genotype, each
purified from 1 to 2 mouse brains. Curve fitting was performed
following a single exponential and setting a maximal phagocytosis
at 5 h following (Slobodov et al., 2001). ApoD-KO myelin delays
macrophage phagocytosis independently of the macrophage
genotype. (C) Slope of data shown in B for WT and ApoD-KO
macrophages, representing the accumulation rate of DiI-positive
macrophages. (D) The exogenous addition of purified human ApoD
to ApoD-KO TG-elicited macrophages rescues the WT levels of
myelin phagocytosis in a concentration dependent manner. Statistical
differences were assayed by ANOVA followed by a Multiple
Comparison Holm-Sidak test (B), and Student’s t-Test (C,D).
Asterisks show statistically significant differences (P < 0.05).
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FIGURE 8 | Myelin degradation by macrophages is delayed in the
absence of ApoD. (A) Degradation assays in cultured macrophages
exposed for 60min to myelin of either WT or ApoD-KO genotype
followed by immunoblot analyses of Mbp and Mag at four time points
after removal of myelin. (B) Band densitometry of Mbp and Mag
normalized to β-actin along the four time points explored, and
percentually referred to t = 0. Average and s.e.m. of three macrophage
samples are shown. (C) Band densitometry of Mbp and Mag at t = 0
normalized to β-actin. (D) Size distribution of phagocytosed particles of
WT and ApoD-KO myelin referred as a percentage of total number of
myelin particles. Right inset shows the number of particles with area
<50μm2. Four myelin phagocytosis experiments (6–8 10×
fields/experiment) were analyzed for each myelin genotype. (E)
UPLC-MS analysis of phosphatidylcholines (PC) and phosphatidylserines
(PS) in WT and ApoD-KO myelin preparations. The plots represent the
average ± SD of 6 independent myelin preparations, each extracted
from two brains/genotype. Statistical differences were assayed by
ANOVA followed by a Multiple Comparison Holm-Sidak test (B), and
Student’s t-Test (C,E). Asterisks show statistically significant differences
(P < 0.05).
t = 0 (60min after myelin exposure) the decrease in total Mbp
or Mag protein content in macrophages (Figure 8C) agrees with
the reduction observed in flow cytometry experiments. An initia-
tion delay combined with inefficient degradation agrees with the
delayed myelin clearance observed in vivo.
To further confirm the ApoD-dependent degradation defi-
ciency, we measured the area distribution of WT and ApoD-KO
myelin particles phagocytosed by TG-activated macrophages
(Figure 8D). We found that larger particles of ApoD-KO myelin
(gray arrow in Figure 8D) are more represented in the percent
distribution of particle sizes present inside macrophages, while
the total number of small (<50μm2) WT myelin particles is >2-
fold higher than that of ApoD-KO myelin (black arrowhead in
inset of Figure 8D). The median particle size was 7.6μm2 in
WT and 17.3μm2 in ApoD-KO. These differences in particle size
are not present in the original DiI-labeled myelin preparations
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of either genotype since the area distribution of isolated myelin
particles is not statistically different between WT and ApoD-KO
myelin preparations (Figure 5C, with median values of 3.3 and
3μm2 in WT and ApoD-KO myelin, respectively). Also, the size
comparison between crude and phagocytosed myelin reveal that
the differences in ApoD-KO particles found inside macrophages
must be due to accumulation of non-degraded material, as the
median size of particles inside macrophages is larger than the
median size measured in crude myelin.
The anomalous phagocytosis initiation and delayed degrada-
tion of myelin particles could be due to differences in myelin
composition caused by the absence of ApoD. Using LC/MS/MS,
we evaluated in our myelin preparations the amount of the two
major phospholipid classes that conditionmyelin recognition and
phagocytosis: phosphatidylcholines (PCs), related to myelinolitic
potential, and phosphatidylserines (PSs), that act as “eat me” sig-
nals (Hall and Gregson, 1971; Bogie et al., 2013). Figure 8E shows
the overall amounts of PCs and PSs in WT and ApoD-KO myelin
samples (a list of the detected phospholipids within these classes
is shown in Table S1). No differences in the net content of these
phospholipids are evidenced, although other compositional dif-
ferences or redox states of myelin lipids cannot be disregarded
as a possibility, given the alterations of LPC and AA observed
in vivo.
Macrophage activation in response to myelin
The results above prompted us to test whether macrophage
activation by myelin also depends on ApoD in simplified
experimental paradigms to help isolate key variables. We
evaluated Galectin-3 protein expression in naïve peritoneal
macrophages upon myelin exposure. WT macrophages show
increased Galectin-3 expression upon exposure tomyelin, but this
induction is absent in myelin-fed naïve macrophages from ApoD-
KO mice (Figure 9A). When Galectin-3 expression is tested in
TG-activated macrophages exposed to myelin of each genotype
in the degradation assay (Figure 9B), we observe a decrease of
Galectin-3 over time in WT macrophages, as expected for a
successful phagocytic activity. However, ApoD-KO macrophages
maintain elevated levels of Galectin-3 at the end of the explored
time window, supporting the notion of less efficient myelin
degradation.
The lack of Galectin-3 response in naïve ApoD-KO
macrophages and the lower initial level of Galectin-3 in
TG-elicited ApoD-KO macrophages add support to the role of
ApoD in the myelin-macrophage initial recognition process. It
also indicates that the robust induction of Galectin-3 arising
from macrophages infiltrating the injured ApoD-KO nerve in
vivo (as shown above) must be the combined result of inefficient
macrophages accumulating in the nerve.
In summary, the in vitro assays performed with cultured
peritoneal macrophages reveal both phagocytosis initiation and
progression as two distinct processes affected by ApoD. Galectin-
3 responses are clearly modulated by ApoD in both isolated
macrophages in vitro and infiltrating macrophages in the injured
nerves in vivo. A delayed initiation and inefficient myelin degra-
dation when ApoD is missing explain the results observed in vivo
in the early phase of WDR explored in this work.
FIGURE 9 | Macrophage response to myelin is impaired in the absence
of ApoD. (A) Immunoblot analysis of Galectin-3 expression in non-elicited
peritoneal macrophages of WT and ApoD-KO mice incubated with myelin.
ApoD-KO macrophages do not induce Galectin-3 expression upon myelin
exposure. The plot represents average ± SD of 3 independent
experiments. (B) Galectin-3 immunoblot of macrophages exposed for
60min to myelin of either WT or ApoD-KO genotype, and explored at t = 0
and 10 h after removal of myelin. Band densitometry was normalized to
β-actin. Statistical differences were assayed by Student’s t-Test. Asterisks
show statistically significant differences (P < 0.05).
DISCUSSION
The aim of this work is to gain knowledge into the mechanism
by which the Lipocalin ApoD contributes to axon regeneration in
peripheral nerves after a crush injury. In our previous work we
found that axon regeneration is delayed in ApoD-KO mice sci-
atic nerves studied 14 and 48d-PCI, probably as a consequence of
defects inmyelin clearance (Ganfornina et al., 2010). These results
open new and early roles for ApoD in controlling phagocytosis
by SCs and macrophages that demand further exploration, and
that deviate from the initial proposals of potential functions in
remyelination. Thus, we have searched for ApoD contributions
at 7d-PCI, an early time point of the WDR process when SCs
are undergoing a profound phenotypic change (Arthur-Farraj
et al., 2012). These denervated SCs and resident macrophages
start phagocytosingmyelin debris, and their signals recruit blood-
derived macrophages (reviewed by Martini et al., 2008; Gaudet
et al., 2011; Rotshenker, 2011).
ApoD EXPRESSION AND FUNCTION IN THE INTACT NERVE
A detailed description of the expression and cellular localization
of ApoD in the uninjured nerve is needed to fully understand
the subsequent response to injury. Our co-localization experi-
ments with immunofluorescence and cell type-specific markers
(Figure 1) reveal both myelinating and non-myelinating SCs as
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the major cell types expressing ApoD in intact PNS nerves. Our
results also disfavor a long-standing view of fibroblasts, abundant
in the ApoD-negative perineurium, as a major source of the pro-
tein (Boyles et al., 1990; Spreyer et al., 1990). Interestingly, not
every SC is ApoD-positive in the intact sciatic nerve, in agree-
ment with our previous results in the CNS (Ganfornina et al.,
2005), which suggests that particular functional states of SCs ben-
efit from ApoD expression. These results suggest the existence
of a regulated transient or intermittent expression of ApoD by
SCs in normal conditions. This basal expression, in addition to
being required for myelin maintenance (Ganfornina et al., 2010),
might contribute to a fast response to an eventual injury. While
in this basal mode of expression, ApoD functions as a “break”
signal, avoiding the overproduction of pro-inflammatory, pro-
myelinolitic, and pro-phagocytosis factors (Tnf, cPLA2, LPC, AA,
Galectin-3; Figures 2, 4, 5).
ApoD EXPRESSION IN THE INJURED NERVE AND ITS ASSOCIATION
WITH MYELIN
We confirmed the up-regulation by injury of ApoD protein,
which can be compared with the results obtained in the rat
(Boyles et al., 1990). SCs undergoing the phenotypic switch to
a repair-devoted cell are responsible for the ApoD up-regulation
upon injury (Figure 1). Seven days after a crush injury these
ApoD-positive denervated SCs are phagocytosing myelin parti-
cles while attracting blood-derivedmacrophages to the injury site.
Macrophage recruitment is increasing at this time and myelin
removal continues until the second week after injury. Then,
the nerve environment is cleared of regeneration-inhibitory fac-
tors and axons are extending toward their targets (reviewed by
Huebner and Strittmatter, 2009). ApoD might have a signaling
role for subsequent myelin clearance by SCs and macrophages,
since myelin debris present in the 7d-PCI crush site and dis-
tal injury region are also ApoD positive (Figure 1). We find
ApoD associated with the isolated myelin membrane prepara-
tions (Figure 6D), and an association of ApoD with myelin has
been previously reported (Suresh et al., 1998; Jahn et al., 2009).
This result and the effects of the exogenous addition of ApoD on
the phagocytosis assays in vitro clearly point to an active role of
ApoD, directly or associated with myelin membranes, in mod-
ulating the myelin-phagocyte interaction and the progression of
phagocytosis.
ApoD CONTROLS PRO-INFLAMMATION AND MACROPHAGE
RECRUITMENT EXTRACELLULAR SIGNALS
Upon injury, ApoD controls the cytokine and chemokine network
organized by nerve resident cells in a particular and specific man-
ner: only a subset of these extracellular signals is ApoD-dependent
(Figure 2). Pro-inflammatory cytokines Il1β and Il6, expressed by
SCs and macrophages (Shamash et al., 2002), and by fibroblasts
and macrophages (Bolin et al., 1995; Tofaris et al., 2002) respec-
tively, as well as the anti-inflammatory cytokine Il10 expressed by
macrophages of the M2 phenotype and involved in tissue repair
(Mantovani et al., 2013), are independent of ApoD expression.
The metalloprotease Mmp-9 is induced by Tnf in SCs, reg-
ulates the early phases of phagocytic cell activation, and con-
trols the number of resident phagocytic cells in injured nerves
(Kobayashi et al., 2008; Chattopadhyay and Shubayev, 2009).
Mmp-9 mRNA expression is already decreased by 7d-PCI in
our samples, and behaves similarly in both genotypes. These
data, and those obtained from nerves cultured ex vivo show-
ing levels of resident phagocyte markers unaffected by the ApoD
genotype (Figures 4E–G), indicate that the number of resident
macrophages and SCs is not influenced by ApoD.
Curiously, the cytokines and chemokines controlled via Toll-
like receptor (TLR) signaling are the ones altered by ApoD. The
WT transcriptional response of these cytokines and chemokines
occurs early (1–2 days) after crush injury, and by 7 days their
levels are returning to almost basal levels (Kleinschnitz et al.,
2004; Iwatsuki et al., 2013). Again ApoD might exert a “break”
function on the post-injury levels of the inflammatory cytokine
Tnf, expressed by denervated SCs and macrophages (Shamash
et al., 2002), and of the chemokine Ccl2/MCP1 that partici-
pates in macrophage recruitment and activation (Tofaris et al.,
2002). Without ApoD, an exacerbated and very specific pro-
inflammatory response, related to macrophage recruitment and
activation, takes place and persists longer. Denervated SCs are still
sending recruitment signals to hematogenous macrophages, and
these cells are entering the nerve in large numbers according to
the expression levels of the macrophage markers (Figures 3B–D)
and to our previous results showing increased numbers of
macrophages at late WDR stages (Ganfornina et al., 2010).
ApoD CONTROLS LOCAL MACROPHAGE-ACTIVATING AND
PRO-PHAGOCYTOSIS FACTORS
Our data demonstrate that ApoD also controls local cues
influencing cell activation and phagocytosis, Galectin 3 and
Complement receptor-3 (CR3-Cd11b). The β-galactoside bind-
ing protein Galectin-3 is expressed and secreted by SCs and
macrophages while they clear up axon and myelin debris in
injured nerves, and it facilitates the re-programming of the
macrophage response toward an anti-inflammatory M2 pheno-
type (Rotshenker, 2009). The heterogeneous overlap of Galectin-
3 and ApoD in SCs of WT injured nerves at 7d-PCI (Figure 4B)
reveals that two cellular processes are taking place: myelin scav-
enging by Galectin-3-positive phagocytic SCs and the launch
of remyelination by Galectin-3-negative SCs. In the ApoD-KO
injured nerves, the abundance of Galectin-3-positive myelin pro-
files (Figure 4D) reflects active phagocytosis by both SCs and
macrophages, and supports the notion that myelin scavenging is
predominant at this time point when ApoD is absent. Therefore,
through controlling the expression of Galectin-3, ApoD favors
a timely switch to a M2 repair macrophage phenotype. The
sciatic nerve explant experiments (Figures 4E–G) demonstrate
that these effects of ApoD are exerted mostly on blood-derived
infiltrating macrophages.
The activated-macrophage membrane glycoprotein CR3-
Cd11b mediates myelin phagocytosis by binding myelin, either
directly or through C3bi-dependent opsonization (van der Laan
et al., 1996; Reichert et al., 2001; Rotshenker, 2003). ApoD also
alters the expression of CR3-Cd11b (Figures 3C,D) further sup-
porting its role as a modulator of macrophage activation.
Thus, upon injury ApoD helps to control the number and
activation state of the phagocytic cells recruited to the lesion. If
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ApoD normally restrains these factors, why is myelin less effi-
ciently cleared up from the lesion when the “break” is removed
in the ApoD-KO nerves?
ApoD PROMOTES MYELIN-MACROPHAGE RECOGNITION AND MYELIN
DEGRADATION
Our analysis in peritoneal macrophages fed with purified
myelin reveals two key effects of ApoD: (1) ApoD potentiates
macrophage-myelin interaction, since feeding macrophages with
ApoD-KO myelin always delays myelin uptake (Figures 7A,B,
8C) and ApoD is needed for appropriate Galectin-3 expression
of naïve macrophages upon exposure to myelin (Figure 9A). (2)
ApoD promotes efficient myelin degradation, since myelin-
positive macrophages accumulate faster without ApoD
(Figure 7C), Mbp and Mag proteins remain longer inside
macrophages (Figures 8A,B), and macrophages accumulate
larger myelin particles (Figure 8D). These effects are in agree-
ment with the persistence of myelin in injured ApoD-KO nerves
48d-PCI (Ganfornina et al., 2010).
We found that adding soluble ApoD to myelin prior to feeding
ApoD-KO macrophage cultures results in a rescue of WT phago-
cytosis parameters, by decreasing the accumulation of myelin-
positive macrophages (Figure 7D). We thus propose that ApoD,
present in the macrophage environment and able to interact with
myelin debris, controls the cell response to myelin at two dis-
tinct stages, initiation and progression, and helps to efficiently
complete the phagocytosis process.
ApoD is not dispensable for myelin-macrophage recognition
and myelin degradation processes in vivo: if myelin-macrophage
interaction and phagocytosis progression is inefficient (when
ApoD is missing), more macrophages and more “eat-me” signals
are required.
The myelin-macrophage recognition promoting function of
ApoD can be exerted from the extracellular milieu. However,
a facilitation of myelin degradation by ApoD would proba-
bly require ApoD to function inside the phagocytic cells. We
have already shown that ApoD is internalized by glial cells
(Bajo-Grañeras et al., 2011). Remarkably, homologs of ApoD in
Drosophila promote autophagy flux and protein aggregate clear-
ance in a polyglutamine-based neurodegenerative disease model
(del Caño-Espinel et al., unpublished observations). Our data
point therefore to ApoD as a multifunctional protein with both,
extracellular functions modulating the availability of important
signaling lipids (see below), and intracellular functions regulating
degradation processes inside cells.
THE LIPOCALIN ApoD CONTROLS THE FATE OF LIPID MEDIATORS
INFLUENCING INFLAMMATORY STATE, MACROPHAGE RECRUITMENT
AND MYELIN RECOGNITION
Phagocytic cells (denervated SCs and macrophages) express upon
injury several members of the phospholipase A2 family (PLA2) in
response to MCP1 and Tnf (Murakami et al., 1997). Two impor-
tant products of PLA2 activation in an injured nerve are LPC
and AA. In addition to its myelinolitic activity, LPC promotes
MCP1 expression by macrophages (Murugesan et al., 2003), thus
generating an amplifying loop ultimately conditioning the extent
of macrophage infiltration. At the same time, eicosanoids are
generated by the oxidation of AA and they contribute to the
pro-inflammatory state after injury.
ApoD has been reported to bind AA in vitro (Morais Cabral
et al., 1995; Vogt and Skerra, 2001) and to reduce oxidized lipids
through a conserved Met residue at the entrance of the binding
pocket (Bhatia et al., 2011). Measuring free AA in WT nerves by
mass spectrometry confirms the expected rise of AA upon injury
(Figure 5E), which correlates with the observed increase in cPLA2
expression and phosphorylation (Figures 5B,C). Interestingly, a
significant increase of AA was also observed in the intact nerve
when ApoD is absent. Although a previous report had suggested
an ApoD control of free AA, based on AA mobilization after
ApoD addition to cell cultures (Thomas et al., 2003), our data
demonstrate for the first time that an absence of ApoD increases
free AA levels in a live organism. Since cPLA2 alpha is induced and
phosphorylated in ApoD-KO nerves similarly to WT nerves, the
lower AA levels measured after injury are probably due to other
effects of ApoD deficiency. Potential contributing factors could be
a lower expression or activity of some other PLA2, faster oxidative
catabolism of AA, or increased compensatory reincorporation
into phospholipids or triglycerides. Although the elucidation of
this mechanism exceeds the scope of this manuscript, our data
strongly support a role for ApoD in the control of free AA
availability and fate after injury.
The Lipocalin α-1-acid glycoprotein, is known to bind LPC
and act as a carrier of extracellular LPC from dying cells to
macrophages, contributing as a “presenting agent” to signal the
presence of phagocytable material (Ojala et al., 2006). Here we
demonstrate that ApoD can bind LPC and control its avail-
ability in the nerve tissue. By performing the same molecular
role as α-1-acid glycoprotein, ApoD would favor myelin recog-
nition, thus explaining the results obtained with macrophages
in vitro, and would control macrophage recruitment, by mod-
ulating the extent of LPC-triggered MCP1 expression observed
in vivo.
In summary, the differences in myelin lipid processing could
be the major causal factors for the ApoD-KO inflammatory state,
increasedmacrophage infiltration and delayedmyelin recognition
and degradation.
FUTURE DIRECTIONS AND CONCLUSIONS
In this work we demonstrate an early role for a lipid binding
protein, the Lipocalin ApoD, in several key processes control-
ling the pace of WDR. The crucial role of denervated SCs in
these processes, and the reprogramming of these cells toward a
repair-devoted phenotype, are known to be dependent on c-Jun
activation after injury (Arthur-Farraj et al., 2012). Since ApoD
is a direct downstream target of the JNK pathway in other sys-
tems (Hull-Thompson et al., 2009; Bajo-Grañeras et al., 2011),
it is reasonable to hypothesize that ApoD is one of the effec-
tor genes whose expression is triggered by c-Jun activation, early
after injury, as part of the regeneration programming of the
transdifferentiated SCs.
Our data demonstrate the existence of ApoD-dependent con-
stitutive differences in the basal inflammatory state, as well as
in the dynamics of post-injury phagocyte-myelin interaction
and myelin breakdown, where the levels of pro-inflammatory
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signaling proteins and lipid mediators are altered in the absence
of ApoD. We propose a dual molecular mechanism of action that
rests on extracellular binding of ApoD to myelin-derived mem-
brane lipids and intracellular promotion of myelin degradation
flow by ApoD. After periods of a steady state “idle”-mode of
expression in Schwann cells of the intact nerve, ApoD expression
is boosted in transdifferentiated Schwann cells after injury, and is
present in the myelin debris at the injury site. There, ApoD is able
to trigger the appropriate macrophage response and allows for a
normal extent and a regular pace of inflammation initiation and
termination. This knowledge should help develop ApoD-based
pro-regenerative therapies.
ITEMIZED CONCLUSIONS
1. Apolipoprotein D (ApoD), a lipid-binding extracellular pro-
tein, is expressed in subsets of myelinating and non-
myelinating Schwann cells (SCs) in the sciatic nerve. It is
associated to myelin membranes both in vivo and in myelin
preparations. ApoD expression is boosted in the denervated,
repair-devoted, SCs as part of the early response to injury.
2. ApoD modulates the cytokine-chemokine network organiz-
ing myelin clearance, particularly the response of Tnf and
Ccl2/MCP1, both controlled via Toll-like receptor (TLR) sig-
naling.
3. ApoD conditions the cellular response to injury, controlling
the infiltration of macrophages and the expression of the pro-
phagocytosis molecule Galectin-3, without major alterations
in resident macrophages or phagocytic SCs.
4. The control of macrophage behavior in vivo is consistent with
the myelin phagocytosis assays in vitro, which reveals two key
effects of ApoD:
a. ApoD potentiates macrophage-myelin interaction. Feeding
macrophages with ApoD-KO myelin always delays myelin
uptake. ApoD is needed for an appropriate Galectin-3
expression of naïve macrophages upon exposure to myelin.
b. ApoD promotes efficient myelin degradation. Without
ApoD, myelin-positive macrophages accumulate faster in
the phagocytosis assays, it takes longer to degrade Mbp and
Mag proteins, and macrophages accumulate larger myelin
particles.
5. ApoD, already known to bind AA, is able to bind lysophos-
phatidylcholine (LPC), a previously unknown ligand for this
Lipocalin.
6. In vivo, ApoD controls basal and injury-triggered AA and LPC
levels, two major products of phospholipases that operate dur-
ing myelinolysis and work as signaling lipids in the injured
nerve.
In summary, our work reveals novel molecular and cellular mech-
anisms by which the Lipocalin ApoD benefits nerve injury reso-
lution. It highlights the importance of this lipid binding protein
in the availability of extracellular signaling lipids and in the con-
trol of macrophage responses to myelin at two distinct stages,
initiation and progression.
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Figure S1 | The amounts of myelin debris show no differences in WT and
ApoD-KO nerves at 7d-PCI. (A) Immunoblot analysis of Mbp in intact
nerves and in the region distal to the injury site at 7d-PCI. Protein band
intensity was normalized to β-actin. No difference in the clearing of
Mbp-positive myelin debris is detected after injury in ApoD-KO nerves. (B)
Representative images of Mbp immunohistochemistry in sagittal sections
of the lesion region at 7d-PCI. Arrows point at Mbp-positive myelin bodies.
(C) Myelin staining with Luxol Fast Blue in sagittal sections of the lesion
region of crushed nerves at 7d-PCI. Calibration bars: 50μm. Statistical
differences were assayed by Student’s t-Test.
Figure S2 | Characterization of myelin phagocytosis by cultured peritoneal
macrophages. (A) Fluorescence microscopy of DiI-labeled myelin
phagocytosis by TG-elicited peritoneal macrophages after 60min of
co-incubation (representative examples are shown). Calibration bars: 50
(upper panel) and 25μm (lower panel). (B) Myelin phagocytosis time
course in TG-elicited peritoneal WT macrophages incubated for up to 24 h
with non-labeled myelin from WT mice. The extent of phagocytosis is
quantified by the presence of the Mbp myelin protein in the macrophage
cell lysates after extensive exchange of the culture medium. Mbp band
intensity was normalized to β-actin. The maximum signal was detected at
1 h of co-incubation.
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